NetworkNewsBreaks – MetAlert Inc. (MLRT) Feature
Post# of 271
(Total Views: 154)
Posted On: 12/07/2022 3:19:07 PM
NetworkNewsBreaks – MetAlert Inc. (MLRT) Featured in Research Report
Ludlow Research has announced that it updated its research opinion on MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring. The update is based on MetAlert’s elimination of toxic debt, as well as the launch of new medical device products for cognitive markets. “Toxic debt, or variable convertible notes, are a form of debt, which sometimes convert at deep discounts to market price, and are major contributors to shareholder dilution and price instability for small issuers. In recent months, MetAlert extinguished all of their toxic convertible notes from their balance sheet, which should now provide increased stability to their public float,” the summary reads. “The influx of new chips in Q4 2022 should significantly increase production of SmartSole units in early 2023. This ramp-up in production should help fulfill backorders currently in place and increase revenues in the coming months. The elimination of toxic debt, improved guidance to their NFC operations, and launch of new medical devices geared towards the geriatric and autism health care markets now places the company in a much healthier position going forward into 2023. For these reasons, Ludlow Research has updated its coverage on MetAlert Inc. (OTC: MLRT) with a ‘speculative’ valuation target of $1.00 to $1.25 per share.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Ludlow Research has announced that it updated its research opinion on MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring. The update is based on MetAlert’s elimination of toxic debt, as well as the launch of new medical device products for cognitive markets. “Toxic debt, or variable convertible notes, are a form of debt, which sometimes convert at deep discounts to market price, and are major contributors to shareholder dilution and price instability for small issuers. In recent months, MetAlert extinguished all of their toxic convertible notes from their balance sheet, which should now provide increased stability to their public float,” the summary reads. “The influx of new chips in Q4 2022 should significantly increase production of SmartSole units in early 2023. This ramp-up in production should help fulfill backorders currently in place and increase revenues in the coming months. The elimination of toxic debt, improved guidance to their NFC operations, and launch of new medical devices geared towards the geriatric and autism health care markets now places the company in a much healthier position going forward into 2023. For these reasons, Ludlow Research has updated its coverage on MetAlert Inc. (OTC: MLRT) with a ‘speculative’ valuation target of $1.00 to $1.25 per share.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Metalert Inc. (MLRT) Stock Research Links
Scroll down for more posts ▼